• Complain

Joseph S. Bertino - Pharmacogenomics: An Introduction and Clinical Perspective

Here you can read online Joseph S. Bertino - Pharmacogenomics: An Introduction and Clinical Perspective full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. year: 2012, publisher: McGraw-Hill Education, genre: Romance novel. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

No cover

Pharmacogenomics: An Introduction and Clinical Perspective: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Pharmacogenomics: An Introduction and Clinical Perspective" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

A COMPLETE INTRODUCTORY TEXT TO THE FIELD OF PHARMACOGENOMICS

The only pharmacogenomics resource to feature a global author team comprised of PharmDs, MDs, Ph.D.s and social scientists, Pharmacogenomics offers an essential, highly accessible survey of this dynamic discipline. You will find thorough coverage of all need-to-know topics, from individual molecules to systemic diseases, plus anexamination of the latest technologies that are constantly reshaping the field. Pharmacogenomics is cohesively organized into two sections, the first of which reviewsbasic aspects of pharmacogenomics, including ethics, regulatory, science, and drug metabolism, along with a mini course in molecular genetics and testing. The second section highlights the practical application of pharmacogenomics in cardiovascular medicine, immunology, neurology, and other specialties.

FEATURES

  • Important overview of general pharmacogenomics and pharmacogenetics concepts, including geneticvariation in signal transduction and targets, plus a review of the genetic concepts of pharmacogenomics
    • Discussion of regulatory considerations in pharmacogenomics
    • Focus on the role of health care professionals along with a review of related privacy issues,as well as broader ethical, legal, and social considerations
    • In-depth chapters on drug metabolism and transporters
    • Practical, step-by-step guidance on public access to pharmacogenomic testing and patient counseling
    • Up-to-date coverage of non-genetic influences on pharmacogenomics
    • Emphasis on gene-drug interactions
    • Numerous tables and figures
    • Chapter-ending references
    • Concise learning objectives at the beginning of each chapter
    • Case studies to familiarize you with the clinical relevance of pharmacogenomics in each specialty
  • Joseph S. Bertino: author's other books


    Who wrote Pharmacogenomics: An Introduction and Clinical Perspective? Find out the surname, the name of the author of the book and a list of all author's works by series.

    Pharmacogenomics: An Introduction and Clinical Perspective — read online for free the complete book (whole text) full work

    Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Pharmacogenomics: An Introduction and Clinical Perspective" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

    Light

    Font size:

    Reset

    Interval:

    Bookmark:

    Make

    Notice

    Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs.

    Copyright 2013 by The McGraw-Hill Companies Inc All rights reserved Printed - photo 1

    Copyright 2013 by The McGraw-Hill Companies Inc All rights reserved Printed - photo 2

    Copyright 2013 by The McGraw-Hill Companies, Inc. All rights reserved. Printed in the United States of America. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a data base or retrieval system, without the prior written permission of the publisher.

    ISBN: 978-0-07-181371-6
    MHID: 0-07-181371-3

    The material in this eBook also appears in the print version of this title: ISBN: 978-0-07-174169-9, MHID: 0-07-174169-0.

    All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after every occurrence of a trademarked name, we use names in an editorial fashion only, and to the benefit of the trademark owner, with no intention of infringement of the trademark. Where such designations appear in this book, they have been printed with initial caps.

    McGraw-Hill eBooks are available at special quantity discounts to use as premiums and sales promotions, or for use in corporate training programs. To contact a representative please e-mail us at bulksales@mcgraw-hill.com.

    [credits or nonstandard disclaimers from print book copyright page]

    TERMS OF USE

    This is a copyrighted work and The McGraw-Hill Companies, Inc. (McGraw-Hill) and its licensors reserve all rights in and to the work. Use of this work is subject to these terms. Except as permitted under the Copyright Act of 1976 and the right to store and retrieve one copy of the work, you may not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works based upon, transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it without McGraw-Hills prior consent. You may use the work for your own noncommercial and personal use; any other use of the work is strictly prohibited. Your right to use the work may be terminated if you fail to comply with these terms.

    THE WORK IS PROVIDED AS IS. McGRAW-HILL AND ITS LICENSORS MAKE NO GUARANTEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANY INFORMATION THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill and its licensors do not warrant or guarantee that the functions contained in the work will meet your requirements or that its operation will be uninterrupted or error free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone else for any inaccuracy, error or omission, regardless of cause, in the work or for any damages resulting therefrom. McGraw-Hill has no responsibility for the content of any information accessed through the work. Under no circumstances shall McGraw-Hill and/or its licensors be liable for any indirect, incidental, special, punitive, consequential or similar damages that result from the use of or inability to use the work, even if any of them has been advised of the possibility of such damages. This limitation of liability shall apply to any claim or cause whatsoever whether such claim or cause arises in contract, tort or otherwise.

    Dedication

    We dedicate this textbook to Dr. Werner Kalow, teacher, mentor, humanitarian, and one of the fathers of Pharmacogenomics.

    Contents

    SECTION I
    GENERAL CONCEPTS

    Roy L. Hawke, PharmD, PhD

    Andrea Gaedigk, MS, PhD

    Andrea Gaedigk, MS, PhD, & Xia Yang, PhD

    Markus Paulmichl, MD,
    Marc Maliepaard, PhD, Marisa Papaluca, MD,
    & Christian Grimstein, PhD

    Joseph D. Ma, PharmD,
    Karen E. Lewis, MS, MM, CGC,
    & Joseph S. Bertino Jr., PharmD, FCP, FCCP

    Su-Jun Lee, PhD, Sang-Seop Lee, PhD,
    & Jae-Gook Shin, MD, PhD

    Michael Murray, PhD, DSc

    Shirley M. Tsunoda, PharmD,
    Dallas Bednarczyk, PhD, &
    Hideaki Okochi, PhD

    Shirley K. Seo, PhD, &
    Anne N. Nafziger, MD, PhD, MHS

    Mary W. Roederer, PharmD, BCPS,
    Shanna K. OConnor, PharmD, BCPS, &
    Stefanie P. Ferreri, PharmD, BCACP, CDE

    Mark Bounthavong, PharmD,
    Christine M. Nguyen, PharmD, BCPS,
    & Margaret Mendes, PharmD

    SECTION II
    CLINICAL APPLICATION OF PHARMACOGENOMICS

    Christina L. Aquilante, PharmD, &
    Robert Lee Page II, PharmD, MSPH, FCCP,
    FAHA, BCPS

    Shashi Amur, PhD, &
    Lawrence Lee Soon-U, MD, PhD

    Ogechi Ikediobi, PharmD, PhD,
    Julie Nangia, MD, &
    Meghana V. Trivedi, PharmD, PhD

    David A. Mrazek, MD, FRCPsych

    Mary S. Hayney, PharmD, MPH, FCCP, BCPS

    Francis M. Gengo, PharmD, FCP,
    & Michelle M. Rainka, PharmD

    Takahisa Furuta, MD, PhD,
    Mitsushige Sugimoto, MD, PhD,
    & Naohito Shirai, MD, PhD

    Melanie S. Joy, PharmD, PhD

    Authors

    Shashi Amur, PhD

    Expert Regulatory Scientist
    Genomics Group, Office of Clinical Pharmacology,
    Office of Translational Sciences, Center for Drug
    Evaluation and Research, Food Drug Administration,
    Silver Spring, Maryland

    Christina L. Aquilante, PharmD

    Associate Professor, Department of Pharmaceutical
    Sciences, School of Pharmacy, University of Colorado,
    Denver, Aurora, Colorado

    Dallas Bednarczyk, PhD

    Investigator II
    Department of Metabolism & Pharmacokinetics,
    Novartis Institutes for BioMedical Research, Inc.,
    Cambridge, Massachusetts

    Joseph S. Bertino Jr., PharmD, FCP, FCCP

    Principal
    Bertino Consulting
    Schenectady, New York
    and
    Associate Professor of Pharmacology
    College of Physicians and Surgeons
    Columbia University
    New York, New York

    Mark Bounthavong, PharmD

    Pharmacoeconomics Clinical Specialist, Veterans Affairs
    San Diego Healthcare System; Health Sciences Assistant
    Clinical Professor, UCSD Skaggs School of Pharmacy

    Next page
    Light

    Font size:

    Reset

    Interval:

    Bookmark:

    Make

    Similar books «Pharmacogenomics: An Introduction and Clinical Perspective»

    Look at similar books to Pharmacogenomics: An Introduction and Clinical Perspective. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


    Reviews about «Pharmacogenomics: An Introduction and Clinical Perspective»

    Discussion, reviews of the book Pharmacogenomics: An Introduction and Clinical Perspective and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.